Reducing Legal Risks in the Sales and Marketing of Medical Devices

In a new era of heightened scrutiny, there is one place where you can learn how to reduce the risk of massive fi nes, litigation costs, misconduct charges, guilty pleas, negative publicity and more - ACI’s 12th National Summit on Reducing Legal Risks in the Sales and Marketing of Medical Devices. This annual conference will enable you to reshape your compliance programs to refl ect recent legislation and changes in enforcement priorities and to develop corporate policies that protect against future fraud claims.

Never before have device companies been so pressured by issues arising simultaneously on the state, national and international levels. At this uniquely trying time, day-to-day activities can become the focus of inquiries by members of Congress, investigations by federal and/or state prosecutors, and whistleblower claims. Additionally, see how other device manufacturers are responding to Sunshine Act requirements as you benchmark against your peers from: Baxter International, CareFusion, Covidien, Cyberonics, Inc., Fresenius Medical Care, Hollister Incorporated, Medline Industries, Medtronic, Roche Diagnostics Corporation, Smith & Nephew, University of Chicago Medical Center, Wright Medical, and Zimmer Holdings.

The Government Has You Under a Microscope – Learn The Enforcement Priorities for 2012

Prosecutors are using all the tools at their disposal to ensure that fraud and abuse by device manufacturers is kept at bay, including increased fi nes, prosecution of individuals and recalls?. By attending this conference, you will have an unparalleled opportunity to hear directly from government representatives regarding what activities are currently triggering enforcement. Gain insights from: federal and state enforcers:

• J. Gilmore Childers,
  First Assistant U.S. Attorney,
  New Jersey District
• Gejaa Gobena,
  Trial Attorney, Fraud Section, Criminal Division,
  U.S. Department of Justice
• Keith V. Morgan,
  Assistant U.S. Attorney, Deputy Chief, Civil Division,
  District of Columbia District
• Stephanie Morse,
  Assistant Attorney General, Complex Civil Enforcement Bureau,
  State of Florida Office of the Attorney General
• Tracy L. Price,
  Assistant Director,
  FCPA Unit, Division of Enforcement, U.S. Securities & Exchange Commission
• Jeremy Sternberg,
  Deputy Chief, Health Care Fraud Unit,
  U.S. Attorney’s Office, District of Massachusetts.

As Device Operations Become More Global, So Do the Global Compliance RisksIt is not uncommon for multinational device manufacturers to be put on notice that they are being investigated for payments made to foreign physicians and health offi cials in various countries. With FCPA enforcement heating up, and the UK Bribery Actbeginning to take shape, it is critical for you to learn how to build a global compliance program to withstand the scrutiny of multiple countries. Expert speakers from the SEC, Bausch & Lomb, Biomet and Becton Dickinson will share tips for installing adequate internal controls to oversee foreign subsidiaries.

Post-Conference Workshops Complete Your Training

Complement your conference experience and gain hands-on and in-depth guidance on training and contracting. The Interactive Working Group: Executing a Comprehensive Training and Monitoring System to Minimize the Risks of Sending Your Sales Team Into the Field will enable you to see what training techniques your competitors are utilizing and how to most effectively ensure your team is engaging in compliant practices. The Master Class on Drafting an Effective and Compliant Contract Between Device Manufactures and Hospitals will give attendees a better understanding of the requirements for the hospital-manufacturer contract, and highlight what areas are subject to increasing government review.

Register today by calling 1-888-224-2480, faxing 1-877-927-1563, or visiting ACI online at www.americanconference.com/MedicalDevices.

Sponsored by

Media Partners

- Actions -

- Share -